Full-Time

Community Sales Representative

Medical

Posted on 8/19/2026

Deadline 9/2/26
Danone

Danone

10,001+ employees

Global foods and beverages company

Compensation Overview

€52k - €58k/yr

+ Bonus

Sligo, Ireland + 2 more

More locations: Ireland | Galway, Ireland

Hybrid

Field-based role covering Galway, Clare, Longford, Donegal, Leitrim, Mayo, Roscommon and Sligo; regular driving is required. Average office attendance is 2–3 days per week.

Category
Sales & Account Management (1)
Required Skills
Microsoft Office
Sales
Word/Pages/Docs

Get referred to Danone

See people who can refer or advise you

Requirements
  • Proven sales experience in a pharmaceutical or health care sales role is preferred but not essential.
  • Excellent presentation skills are required.
  • An aptitude for selling.
  • Computer literacy in Microsoft Office, including Word and PowerPoint.
  • Success in developing relationships with key medical personnel.
  • A full clean Irish driving licence.
  • Strong time management, organisational and planning skills.
  • Excellent written and verbal communication skills.
  • A teamwork approach and ability to foster collaboration across functions.
  • Ability to establish trust and credibility with health care professionals.
  • A commercial mindset.
  • Analytical capability to decompose problems, build solutions from the ground up, and use insights to develop solutions.
  • A positive, future-oriented perspective, challenging established paradigms and driving for action.
  • A growth mindset, sharing and receiving knowledge and pursuing personal development beyond existing resources.
  • Residence in Galway, Clare, Longford, Donegal, Leitrim, Mayo, Roscommon or Sligo, with willingness to relocate if necessary.
  • Comfort with regular driving to meet customers.
Responsibilities
  • Promote the Nutricia Medical range of products through marketing campaigns and nutritional education to nursing home management and staff, general practitioners, public health nurses, tissue viability nurses, and pharmacists.
  • Arrange one-to-one and group sales calls and appointments, meetings, and presentations.
  • Maintain professionalism to protect Nutricia Advanced Medical Nutrition’s reputation.
  • Provide educational presentations to nursing homes and other health care professionals.
  • Maintain and manage territory accounts.
  • Exhibit Nutricia product ranges at relevant health care professional meetings.
  • Manage the territory effectively and monitor monthly market-share data in alignment with company business strategy.
  • Liaise with the Nutricia team regarding regional educational meetings and presentations.
  • Liaise with the marketing team to develop successful campaigns by providing insight into customer needs.
  • Identify new customers and opportunities to grow the business.
  • Pursue continued educational development by attending relevant study days, reviewing medical literature, and reviewing current best clinical practice.
  • Liaise with distribution and supply chain departments to ensure maximum product availability.
  • Use the data-recording system daily and send monthly reports to the Business Manager.
Desired Qualifications
  • A keen interest in nutrition is preferred but not essential.

Danone is a global food and beverage company with three main divisions: Essential Dairy & Plant-Based products, Waters, and Specialized Nutrition. It markets brands like Actimel, Activia, Alpro, Evian, Nutricia, and Volvic across more than 120 countries with over 100,000 employees. Its products aim to support health through everyday nutrition and hydration, including dairy, plant-based options, and infant nutrition. The company pursues social and environmental goals under the One Planet. One Health framework and seeks B Corp certification by 2025, differentiating itself through a mission-driven approach and broad sustainability commitments.

Company Size

10,001+

Company Stage

IPO

Headquarters

Paris, France

Founded

1919

Get referred to Danone

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • H1 2026 sales reached €13.94 billion, with 3.5% like-for-like growth.
  • Q2 2026 volume/mix rose 1.9%, proving pricing power without losing shoppers.
  • Danone confirmed 2026 guidance on July 29, despite inflation and forex noise.

What critics are saying

  • Paris prosecutors opened probes on February 13, 2026 over cereulide-tainted formula.
  • Aptamil recalls can destroy infant-formula trust and trigger lasting channel delistings.
  • Iran-war shipping and energy spikes force price hikes, risking volume erosion in 2026.

What makes Danone unique

  • Danone’s 2026 growth comes from protein, gut-health, and functional nutrition, not commodity dairy.
  • Its multi-local model drove Q2 2026 gains across EMEA, Americas, and APAC.
  • Made Group and Huel extend Danone into high-margin, high-growth nutrition niches.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Wellness Program

Life Insurance

401(k) Retirement Plan

Parental Leave

Paid Vacation

Flexible Work Hours

Remote Work Options

Hybrid Work Options

Family Planning Benefits

Fertility Treatment Support

Childcare Support

Meal Benefits

Professional Development Budget

Training Programs

Conference Attendance Budget

Tuition Reimbursement

Gym Membership

Growth & Insights and Company News

Headcount

6 month growth

12%

1 year growth

12%

2 year growth

12%
Yahoo Finance
Jul 29th, 2026
Danone delivers $15.7B H1 sales with +3.5% growth, confirms 2026 guidance

Danone reported Q2 2026 sales up 4.2% on a like-for-like basis, with volume/mix increasing 1.9% and price rising 2.3%. The EMEA region grew 3.6%, Americas 4.3%, and APAC 5.2%, driven by competitive performance in China's infant milk formula and strong aqua waters results. For the first half of 2026, sales reached €13.94 billion, up 3.5% like-for-like. Recurring operating margin improved 12 basis points to 13.3%, supported by productivity gains despite inflation. Recurring earnings per share rose 0.9% to €1.92, whilst free cash flow totalled €0.9 billion. The company confirmed its 2026 guidance, expecting like-for-like sales growth between 3% and 5%, with recurring operating income growing faster than sales. Danone recently signed agreements to acquire Huel and Made Group in APAC.

GlobeNewswire
Jun 22nd, 2026
Danone to acquire MADE Group, expanding its presence in the fast-growing healthy nutrition space in Asia Pacific

Press release – Paris, June 22, 2026, 6:00 AM CEST Danone to acquire MADE Group, expanding its presence in the fast-growing healthy nutrition space in...

Yahoo Finance
Apr 23rd, 2026
Danone shareholders approve $2.54 dividend, up 4.7% on 2025 results

Danone's shareholders approved all resolutions at the company's 2026 annual meeting, with 73.08% of total outstanding share capital present or represented. Shareholders backed the 2025 financial statements and a dividend of €2.25 per share in cash, up 4.7% year-on-year. The ex-dividend date is 4 May 2026, with payment on 6 May 2026. The meeting also approved the renewal of terms for Gilles Schnepp as chairman of the board, Valérie Chapoulaud-Floquet as lead independent director, and Sanjiv Mehta. Danone presented its sustainability roadmap, the Danone Impact Journey, and outlined ambitions towards 2030, including its climate strategy. The board continued its global employee share subscription programme, allowing eligible employees in 48 countries to subscribe to new shares at a 30% discount.

CNBC
Apr 7th, 2026
Danone CEO warns Iran war may force price hikes amid soaring costs

Danone CEO Antoine de Saint-Affrique told CNBC that inflationary pressure from the Iran war may lead to higher food prices, though the company is "not there yet" on raising prices. The outcome depends heavily on how the next two to four weeks evolve, he said. The effective closure of the Strait of Hormuz has caused surging energy, fertiliser and shipping costs. Britain's Food and Drink Federation has forecast food inflation of at least 9% by year-end, up from an estimated 3.2% previously. Despite macroeconomic headwinds, de Saint-Affrique expressed confidence in Danone's resilience. The company reported 2.1% price increases and 2.5% volume-led growth in the fourth quarter, and recently acquired protein shake maker Huel.

MarketScreener
Mar 25th, 2026
Danone issues $1.8B triple-tranche bond to extend debt maturity

Danone has successfully issued a triple-tranche bond totalling €1.6 billion equivalent. The offering comprises a €700 million 4-year tranche with a 3.3790% coupon, a €500 million 8-year tranche with a 3.7850% coupon, and a £350 million 6.5-year tranche carrying a 5.3250% coupon. The issue enables Danone to enhance funding flexibility whilst extending debt maturity as part of active liquidity management. Settlement is expected on 1 April 2026, with bonds to be listed on Euronext Paris. The bond was widely subscribed by a diversified investor base, confirming confidence in Danone's business model and credit profile. Danone holds BBB+ ratings from Standard & Poor's and Baa1 from Moody's, both with stable outlooks.